생명과학회지 (Journal of Life Science)

  • 제19권5호
  • /
  • Pages.620-624
  • /
  • 2009
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

인체혈구암세포 U937의 D-Ala2-Leu5-enkephalin처리에 의한 세포 주기 억제 효과

Cell Cycle Arrest by Treatment of D-Ala2-Leu5-enkephalin in Human Leukemia Cancer U937 Cell.

  • 이준혁 (특허청 화학생명공학심사국) ;
  • 최우영 (부산대학교 한의학전문대학원 경락구조의학부) ;
  • 최영현 (동의대학교 한의과대학 생화학교실) ;
  • 최병태 (부산대학교 한의학전문대학원 경락구조의학부)
  • Lee, Jun-Hyuk (Chemistry and Biotechnology Examination Bureau, Korean Intellectual Property Office) ;
  • Choi, Woo-Young (Division of Meridian and Structural Medicine, School of Oriental Medicine. Pusan National University) ;
  • Choi, Yung-Hyun (Department of Biochemistry, College of Oriental Medicine, Dongeui University) ;
  • Choi, Byung-Tae (Division of Meridian and Structural Medicine, School of Oriental Medicine. Pusan National University)
  • 발행 : 2009.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

동면 개시인자로 알려진 DADLE는 여러 연구에 의해 in vivo와 in vitro 상에서 유사 동면 상태를 야기한다. 본 연구는 인체혈구암세포인 U937 세포주의 세포 사멸과 세포 주기 둥에 대한 DADLE의 영향을 살펴보았다. DADLE가 처리된 U937세포는 8${\sim}6$10 ${\mu}$M의 높은 농도에서 세포 증식이 감소하였으며, 0${\sim}6$ ${\mu}$M의 낮은 농도에서 영향이 없었다. DNA flow cytometer를 이용하여 세포 주기를 분석해본 결과 DADLE에 의한 세포 주기 억제가 관찰되었다. DADLE처리에 따른 세포 증식률 감소 및 세포 주기 억제효과를 전사 수준에서 조사한 결과 Bcl-XL, c-IAP-2의 발현 및 survivin의 발현 감소가 관찰되었으며, COX-2의 발현 역시 COX-1의 변화 없이 감소함을 확인하였다. 또한, cyclin E 와 cdk-2, -4 그리고 -6의 발현 역시 감소하는 것을 관찰하였다. Telomere 조절 관련 유전자의 경우도 c-myc과 TERT의 감소, 그리고 TEP-1가 증가하는 현상을 관찰하였다. 이상의 결과는 DADLE를 U937 암세포주에 처리했을 때 세포 주기의 억제를 통하여 life-time을 증가시킬 가능성을 시사하며 이에 관한 지속적인 연구가 필요할 것으로 사료된다.

D-Ala2-Leu5-enkephalin (DADLE), a hibernation inducer, can induce hibernation-like state in vivo and in vitro. We treated U937 human leukemia cancer cells with DADLE and investigated its possible effect on transcription and proliferation. Treatment of U937 cells with DADLE resulted in growth inhibition and induction of apoptotic cell death on high-dose as measured by MTT assay and DNA flow cytometer analysis. Bcl-XL, c-IAP-2 and survivin genes especially showed decreases in mRNA levels. DADLE treatment also inhibited the levels of cyclooxygenase (COX)-2 mRNA without alteration of COX-1 expression. DNA flow cytometer analysis revealed that DADLE caused arrest of the cell cycle on low-dose, which was associated with a down-regulation of cyclin E at the transcriptional level. DADLE treatment induced a marked down-regulation of cyclin-dependent kinase (Cdk)-2, -4 and -6. In addition, treatment with DADLE decreased telomere associated genes such as, c-myc and TERT, and increased TEP-1 in U937 cells. These results suggest that DADLE can be an inhibition agent in the cell cycle of the human leukemia cancer U937 cell.

키워드

참고문헌

  1. Antonsson, B. and J. C. Martinou. 2000. The Bcl-2 protein family. Exp. Cell Res. 256, 50-57 https://doi.org/10.1006/excr.2000.4839
  2. Beatrice, B., V. Lorella, G. B. Maria, M. Giovanni, B. Marco, and M. Manuela. 2006. The effect of the enkephalin DADLE on transcription does not depend on opioid receptors. Histochem. Cell Bio. 126, 189-197 https://doi.org/10.1007/s00418-006-0145-x
  3. Butt, A. J., C. E. Caldon, C. M. McNeil, A. Swarbrick, E. A. Musgrove, and R. L. Sutherland. 2008. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv. Exp. Med. Biol. 630, 189-205 https://doi.org/10.1007/978-0-387-78818-0_12
  4. Caldon, C. E., R. J. Daly, R. L. Sutherland, and E. A. Musgrove. 2006. Cell cycle control in breast cancer cells. J. Cell Biochem. 97, 261-274 https://doi.org/10.1002/jcb.20690
  5. Chiarugi, V., L. Magneli, M. Cinelli, and G. Basi. 1994. Apoptosis and the cell cycle. Cell Mol. Biol. Res. 40, 603-612
  6. Chung, H. K., C. Cheong, J. Song, and H. W. Lee. 2005. Extratelomeric functions of telomerase. Curr. Mol. Med. 5, 233-241 https://doi.org/10.2174/1566524053586635
  7. Genovese, C., D. Trani, M. Caputi, and P. P. Claudio. 2006. Cell cycle control and beyond; emerging roles for the retinoblastoma gene family. Oncogene 25, 5201-5209 https://doi.org/10.1038/sj.onc.1209652
  8. Hiroyuki, I., E. Susumu, Y. Katsuhiko, H. Takayuki, Y. Kohsho, O. Sadayuki, and K. Takashi. 2007. Protective effects of a hibernation-inducer on hepatocyte injury induced by hypothermic preservation. J. Hepatobiliary Pancreat Surg. 14, 509-513 https://doi.org/10.1007/s00534-007-1214-9
  9. Holcik, M., H. Gibson, and R. G. Korneluk. 2001. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6, 253-261 https://doi.org/10.1023/A:1011379307472
  10. Houston, A. and J. O'Connell. 2004. The Fas signalling pathway and its role in the pathogenesis of cancer. Curr. Opin. Pharmacol. 4, 321-326 https://doi.org/10.1016/j.coph.2004.03.008
  11. Howard, A. and S. R. Pelc. 1953. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity 6, 261
  12. Hussein, M. R., A. K. Haemel, and G. S. Wood. 2003. Apoptosis and melanoma: molecular mechanisms. J. Pathol. 199, 275-288 https://doi.org/10.1002/path.1300
  13. Khalil, M. L. 2006. Biological activity of bee propolis in health and disease. Asian Pac. J. Cancer Prev. 7, 22-31
  14. Kousyou, Y., Y. Katsuhiko, O. Sadayuki, E. Susumu, F. Junichiro, and K. Takashi. 2003. DADLE protects liver against Ischemia-reperfusion injury in the rat. J. Surgical Res. 114, 72-77 https://doi.org/10.1016/S0022-4804(03)00196-3
  15. Lieberthal, W., J. S. Koh, and J. S. Levine. 1998. Necrosis and apoptosis in acute renal failure. Semin Nephrol. 18, 505-518
  16. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374, 131-134 https://doi.org/10.1038/374131a0
  17. Schwartz, G. K. 2005. Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy. J. Clin. Oncol. 23, 4499-4508 https://doi.org/10.1200/JCO.2005.18.341
  18. Schwartz, G. K. and M. A. Shah. 2005. Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421 https://doi.org/10.1200/JCO.2005.01.5594
  19. Sherr, C. J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689-3695
  20. Thomas, S. M. 2003. Squirreling away at parkinson's. Drug discovery today 8, 51-52 https://doi.org/10.1016/S1359-6446(02)02570-9
  21. Wang, D. and R. N. Dubois. 2004. Cyclooxygenase-2: a potential target in breast cancer. Semin. Oncol. 31, 64-73
  22. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 https://doi.org/10.1016/0092-8674(95)90385-2